Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats

<p>Abstract</p> <p>Background</p> <p>Oxaliplatin is a key drug in the treatment of colorectal cancer, but it causes severe peripheral neuropathy. We previously reported that oxaliplatin (4 mg/kg, i.p., twice a week) induces mechanical allodynia in the late phase in rats...

Full description

Bibliographic Details
Main Authors: Shirahama Masafumi, Ushio Soichiro, Egashira Nobuaki, Yamamoto Shota, Sada Hikaru, Masuguchi Ken, Kawashiri Takehiro, Oishi Ryozo
Format: Article
Language:English
Published: SAGE Publishing 2012-04-01
Series:Molecular Pain
Online Access:http://www.molecularpain.com/content/8/1/26
_version_ 1828359101595254784
author Shirahama Masafumi
Ushio Soichiro
Egashira Nobuaki
Yamamoto Shota
Sada Hikaru
Masuguchi Ken
Kawashiri Takehiro
Oishi Ryozo
author_facet Shirahama Masafumi
Ushio Soichiro
Egashira Nobuaki
Yamamoto Shota
Sada Hikaru
Masuguchi Ken
Kawashiri Takehiro
Oishi Ryozo
author_sort Shirahama Masafumi
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Oxaliplatin is a key drug in the treatment of colorectal cancer, but it causes severe peripheral neuropathy. We previously reported that oxaliplatin (4 mg/kg, i.p., twice a week) induces mechanical allodynia in the late phase in rats, and that spinal NR2B-containig <it>N</it>-methyl-<sub>D</sub>-aspartate (NMDA) receptors are involved in the oxaliplatin-induced mechanical allodynia. In the present study, we investigated the involvement of Ca<sup>2+</sup>/calmodulin dependent protein kinase II (CaMKII), which is a major intracellular protein kinase and is activated by NMDA receptor-mediated Ca<sup>2+ </sup>influx, in the oxaliplatin-induced mechanical allodynia in rats.</p> <p>Results</p> <p>An increase of CaMKII phosphorylation was found in the spinal cord (L<sub>4-6</sub>) of oxaliplatin-treated rats. This increased CaMKII phosphorylation was reversed by intrathecal injection of a selective CaMKII inhibitor KN-93 (50 nmol, i.t.) and a selective NR2B antagonist Ro 25-6981 (300 nmol, i.t.). Moreover, acute administration of KN-93 (50 nmol, i.t.) strongly reversed the oxaliplatin-induced mechanical allodynia in von Frey test, while it did not affect the oxaliplatin-induced cold hyperalgesia in acetone test. Similarly, oral administration of trifluoperazine (0.1 and 0.3 mg/kg, p.o.), which is an antipsychotic drug and inhibits calmodulin, reduced both mechanical allodynia and increased CaMKII phosphorylation. On the other hand, trifluoperazine at the effective dose (0.3 mg/kg) had no effect on the paw withdrawal threshold in intact rats. In addition, trifluoperazine at the same dose did not affect the motor coordination in rota-rod test in intact and oxaliplatin-treated rats.</p> <p>Conclusions</p> <p>These results suggest that CaMKII is involved in the oxaliplatin-induced mechanical allodynia, and trifluoperazine may be useful for the treatment of oxaliplatin-induced peripheral neuropathy in clinical setting.</p>
first_indexed 2024-04-14T03:37:52Z
format Article
id doaj.art-ab3e8685424e4a71a01db85ac768a6ad
institution Directory Open Access Journal
issn 1744-8069
language English
last_indexed 2024-04-14T03:37:52Z
publishDate 2012-04-01
publisher SAGE Publishing
record_format Article
series Molecular Pain
spelling doaj.art-ab3e8685424e4a71a01db85ac768a6ad2022-12-22T02:14:41ZengSAGE PublishingMolecular Pain1744-80692012-04-01812610.1186/1744-8069-8-26Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in RatsShirahama MasafumiUshio SoichiroEgashira NobuakiYamamoto ShotaSada HikaruMasuguchi KenKawashiri TakehiroOishi Ryozo<p>Abstract</p> <p>Background</p> <p>Oxaliplatin is a key drug in the treatment of colorectal cancer, but it causes severe peripheral neuropathy. We previously reported that oxaliplatin (4 mg/kg, i.p., twice a week) induces mechanical allodynia in the late phase in rats, and that spinal NR2B-containig <it>N</it>-methyl-<sub>D</sub>-aspartate (NMDA) receptors are involved in the oxaliplatin-induced mechanical allodynia. In the present study, we investigated the involvement of Ca<sup>2+</sup>/calmodulin dependent protein kinase II (CaMKII), which is a major intracellular protein kinase and is activated by NMDA receptor-mediated Ca<sup>2+ </sup>influx, in the oxaliplatin-induced mechanical allodynia in rats.</p> <p>Results</p> <p>An increase of CaMKII phosphorylation was found in the spinal cord (L<sub>4-6</sub>) of oxaliplatin-treated rats. This increased CaMKII phosphorylation was reversed by intrathecal injection of a selective CaMKII inhibitor KN-93 (50 nmol, i.t.) and a selective NR2B antagonist Ro 25-6981 (300 nmol, i.t.). Moreover, acute administration of KN-93 (50 nmol, i.t.) strongly reversed the oxaliplatin-induced mechanical allodynia in von Frey test, while it did not affect the oxaliplatin-induced cold hyperalgesia in acetone test. Similarly, oral administration of trifluoperazine (0.1 and 0.3 mg/kg, p.o.), which is an antipsychotic drug and inhibits calmodulin, reduced both mechanical allodynia and increased CaMKII phosphorylation. On the other hand, trifluoperazine at the effective dose (0.3 mg/kg) had no effect on the paw withdrawal threshold in intact rats. In addition, trifluoperazine at the same dose did not affect the motor coordination in rota-rod test in intact and oxaliplatin-treated rats.</p> <p>Conclusions</p> <p>These results suggest that CaMKII is involved in the oxaliplatin-induced mechanical allodynia, and trifluoperazine may be useful for the treatment of oxaliplatin-induced peripheral neuropathy in clinical setting.</p>http://www.molecularpain.com/content/8/1/26
spellingShingle Shirahama Masafumi
Ushio Soichiro
Egashira Nobuaki
Yamamoto Shota
Sada Hikaru
Masuguchi Ken
Kawashiri Takehiro
Oishi Ryozo
Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
Molecular Pain
title Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
title_full Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
title_fullStr Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
title_full_unstemmed Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
title_short Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
title_sort inhibition of ca sup 2 sup calmodulin dependent protein kinase ii reverses oxaliplatin induced mechanical allodynia in rats
url http://www.molecularpain.com/content/8/1/26
work_keys_str_mv AT shirahamamasafumi inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT ushiosoichiro inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT egashiranobuaki inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT yamamotoshota inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT sadahikaru inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT masuguchiken inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT kawashiritakehiro inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats
AT oishiryozo inhibitionofcasup2supcalmodulindependentproteinkinaseiireversesoxaliplatininducedmechanicalallodyniainrats